Antonio Doronzo

ORCID: 0000-0002-6047-6372
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • Breast Cancer Treatment Studies
  • Salivary Gland Tumors Diagnosis and Treatment
  • Hedgehog Signaling Pathway Studies
  • Glioma Diagnosis and Treatment
  • Immunotherapy and Immune Responses
  • Urinary and Genital Oncology Studies
  • CAR-T cell therapy research
  • Pancreatic and Hepatic Oncology Research
  • Pancreatitis Pathology and Treatment
  • HER2/EGFR in Cancer Research
  • TGF-β signaling in diseases
  • Cancer Genomics and Diagnostics
  • Breast Lesions and Carcinomas
  • Bladder and Urothelial Cancer Treatments

Ospedali Riuniti di Foggia
2021-2022

University of Bari Aldo Moro
2016

Salivary gland tumors are relatively rare neoplasms, comprising approximately 3-6% of all head and neck tumors. Parotid carcinoma (PGC) represents 70-80% salivary malignancies. Treatment strategies depend on tumor histology, stage, molecular characteristics, with surgical resection adjuvant radiotherapy being the mainstays treatment for localized disease. Conversely, in advanced stages therapeutic approaches, including chemotherapy targeted agents, more challenging. We present a case report...

10.20944/preprints202410.2047.v1 preprint EN 2024-10-28

Background: Salivary gland tumors are relatively rare neoplasms, comprising approximately 3–6% of all head and neck tumors. Parotid carcinoma (PGC) represents 70–80% salivary malignancies. Treatment strategies depend on tumor histology, stage, molecular characteristics, with surgical resection adjuvant radiotherapy being the mainstays treatment for localized disease. Conversely, in advanced stages, therapeutic approaches, including chemotherapy targeted agents, more challenging. Methods: We...

10.3390/ijtm5010003 article EN cc-by International Journal of Translational Medicine 2024-12-25

Background: Over the past few decades, there has been much debate and research into link between alcohol consumption development progression of pancreatic ductal adenocarcinoma (PDAC). Objectives: To contribute to ongoing discussion gain further insights this topic, our study analysed gene expression differences in PDAC patients based on their history. Methods: end, we interrogated a large publicly available dataset. We next validated findings vitro. Results: Our revealed that with history...

10.3390/medicina59050872 article EN cc-by Medicina 2023-04-30
Coming Soon ...